Search

Search Results

8 results found. Results per page: [ 20 ] [ 40 ] [ 60 ] [ 80 ] [ 100 ] [ 200 ] [ 300 ]

Sort by: [ Publication Date ] [ Score ]

Direction: [ Desc ] [ Asc ]

Year of publication: [ 2026 ] [ 2025 ] [ 2024 ] [ 2023 ] [ 2022 ] [ 2021 ] [ 2020 ] [ 2019 ] [ 2018 ] [ 2017 ] [ 2016 ] [ 2015 ] [ 2014 ] [ 2013 ] [ 2012 ] [ 2011 ] [ 2010 ] [ 2009 ] [ Any ]

• Research PaperVolume 12, Issue 14pp 14391-14405

  The cross-talk between DDR1 and STAT3 promotes the development of hepatocellular carcinoma

  Relevance score: 0.00

  Ye Lin, Haosheng Jin, Xianqiu Wu, Zhixiang Jian, Xiongfeng Zou, Jianfeng Huang, Renguo Guan, Xiangling Wei

  Keywords: hepatocellular carcinoma, DDR1, STAT3, EMT, glutamine metabolism

  Published in Aging on July 27, 2020

  Show abstract
• Research PaperVolume 12, Issue 10pp 9948-9958

  Topoisomerase II-binding protein 1 promotes the progression of prostate cancer via ATR-CHK1 signaling pathway

  Relevance score: 0.00

  Kaiwen Li, Shirong Peng, Zean Li, Yiming Lai, Qiong Wang, Yiran Tao, Wanhua Wu, Qianghua Zhou, Ze Gao, Junxiu Chen, Hui Li, Wenli Cai, Zhenghui Guo, Hai Huang

  Keywords: TopBP1, DDR, prostate cancer, ATR-CHK1

  Published in Aging on May 27, 2020

  Show abstract
• Research PaperVolume 12, Issue 11pp 10194-10210

  Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell lines

  Relevance score: 0.00

  William H. Chappell, Saverio Candido, Stephen L. Abrams, Shaw M. Akula, Linda S. Steelman, Alberto M. Martelli, Stefano Ratti, Lucio Cocco, Melchiorre Cervello, Giuseppe Montalto, Ferdinando Nicoletti, Massimo Libra, James A. McCubrey

  Keywords: TP53, DDR, rapamycin, RAF/MEK/ERK, collagen

  Published in Aging on June 3, 2020

  Show abstract
• RetractionVolume 16, Issue 17pp 12429-12430

  Retraction of: The cross-talk between DDR1 and STAT3 promotes the development of hepatocellular carcinoma

  Relevance score: 0.00

  Ye Lin, Haosheng Jin, Xianqiu Wu, Zhixiang Jian, Xiongfeng Zou, Jianfeng Huang, Renguo Guan, Xiangling Wei

  Keywords: hepatocellular carcinoma, DDR1, STAT3, EMT, glutamine metabolism

• Research PaperVolume 15, Issue 17pp 9217-9229

  Euphorbia factor L1 suppresses breast cancer liver metastasis via DDR1-mediated immune infiltration

  Relevance score: 0.00

  Dongjing Jiang, XiaoQin Gao, RuLan Tan, Xun Liu, Ye Zhu, Li Zhang

  Keywords: Euphorbia factor L1, breast cancer, liver metastasis, immune infiltration, DDR1

  Published in Aging on September 14, 2023

  Show abstract
• Research PaperVolume 13, Issue 21pp 24136-24154

  Mutations in DNA damage response pathways as a potential biomarker for immune checkpoint blockade efficacy: evidence from a seven-cancer immunotherapy cohort

  Relevance score: 0.00

  Wenjing Zhang, Liwen Zhang, Hao Jiang, Yuting Li, Suzhen Wang, Qinghua Wang

  Keywords: immunotherapy, DDR mutations, predictive biomarker, microenvironment, clinical practice

  Published in Aging on November 8, 2021

  Show abstract
• Research PaperVolume 6, Issue 6pp 481-495

  Interaction between ROS dependent DNA damage, mitochondria and p38 MAPK underlies senescence of human adult stem cells

  Relevance score: 0.00

  Aleksandra Borodkina, Alla Shatrova, Polina Abushik, Nikolay Nikolsky, Elena Burova

  Keywords: mesenchymal stem cells, ROS, DDR, senescence

  Published in Aging on June 12, 2014

  Show abstract
• Research PaperVolume 13, Issue 21pp 24171-24191

  LncRNA OTUD6B-AS1 promotes paclitaxel resistance in triple negative breast cancer by regulation of miR-26a-5p/MTDH pathway-mediated autophagy and genomic instability

  Relevance score: 0.00

  Peng-Ping Li, Rong-Guo Li, Yu-Qing Huang, Jin-Pian Lu, Wei-Jun Zhang, Zhen-Yu Wang

  Keywords: chemotherapy resistance, autophagy, genomic instability (GIN), triple negative breast cancer (TNBC), DNA damage response (DDR)

  Published in Aging on November 5, 2021

  Show abstract